Finance

Lists
Why is CRVO down 15,53%?
Dive Deeper
CRVO:NASDAQ
CervoMed Inc
USD 2,72
-15,53%
(-0,50) 1D
12 Okt., 10:11:59 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
USD 2,75
High
USD 2,79
Low
USD 2,61
Mkt. cap
41,12 m
Avg. vol.
221,28 k
Volume
272,42 k
52-wk high
USD 10,00
52-wk low
USD 2,13
EPS
-USD 3,21
Beta
-0,75
Shares outstanding
15,12 m
No. of employees
15
Open
USD 2,75
High
USD 2,79
Low
USD 2,61
Mkt. cap
41,12 m
Avg. vol.
221,28 k
Volume
272,42 k
52-wk high
USD 10,00
52-wk low
USD 2,13
EPS
-USD 3,21
Beta
-0,75
Shares outstanding
15,12 m
No. of employees
15
News stories
From web sources and news partners
About CervoMed Inc
CEO-
Employees15
Founded1995
HeadquartersBoston, Massachusetts, Verenigde State van Amerika
Sector-
Websitecervomed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current USD 2,72
USD 25,00 (+819,12%)
Average
USD 15,50 (+469,85%)
Lowest
USD 7,00 (+157,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
USD 25,00
+819,1%
10/05/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
USD 7,00
+157,4%
10/01/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
USD 18,00
+561,8%
09/29/2026
Boris Peaker
JonesTrading
Buy
Maintained
USD 12,00
+341,2%
09/28/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
USD 21,00
+672,1%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
USD 20,00
+635,3%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
322,57 k
8,73 k
-
-
Cost of goods sold
6,04 m
5,83 m
5,14 m
4,32 m
Cost of revenue
6,04 m
5,83 m
5,14 m
4,32 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,33 m
2,51 m
2,98 m
2,36 m
Operating expense
2,33 m
2,51 m
2,98 m
2,36 m
Total operating expenses
8,37 m
8,34 m
8,11 m
6,68 m
Operating income
-8,04 m
-8,33 m
-8,11 m
-6,68 m
Other non operating income
-1,23 k
3,29 k
-1,02 k
2,00 k
EBT including unusual items
-7,73 m
-8,09 m
-7,96 m
-6,57 m
EBT excluding unusual items
-7,73 m
-8,09 m
-7,96 m
-6,57 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,73 m
-8,09 m
-7,96 m
-6,57 m
Net profit margin
-2 395,34%
-92 680,38%
-
-
Earnings per share
-0,84
-0,88
-0,86
-0,64
Interest and investment income
318,79 k
240,94 k
147,39 k
104,90 k
Interest expense
-
-
-
-
Net interest expenses
318,79 k
240,94 k
147,39 k
104,90 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme